ATE1524T1 - Phenyl- oder phenoxy-substituierte spiroimidazolidindion-derivate, deren pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung. - Google Patents

Phenyl- oder phenoxy-substituierte spiroimidazolidindion-derivate, deren pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung.

Info

Publication number
ATE1524T1
ATE1524T1 AT80300821T AT80300821T ATE1524T1 AT E1524 T1 ATE1524 T1 AT E1524T1 AT 80300821 T AT80300821 T AT 80300821T AT 80300821 T AT80300821 T AT 80300821T AT E1524 T1 ATE1524 T1 AT E1524T1
Authority
AT
Austria
Prior art keywords
spiroimidazolidone
phenyl
derivatives
manufacture
processes
Prior art date
Application number
AT80300821T
Other languages
English (en)
Inventor
Reinhard Sarges
John Belletire
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Application granted granted Critical
Publication of ATE1524T1 publication Critical patent/ATE1524T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT80300821T 1979-03-21 1980-03-19 Phenyl- oder phenoxy-substituierte spiroimidazolidindion-derivate, deren pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung. ATE1524T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/022,400 US4181729A (en) 1979-03-21 1979-03-21 Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
EP80300821A EP0017379B1 (de) 1979-03-21 1980-03-19 Phenyl- oder Phenoxy-substituierte Spiro-imidazolidindion-Derivate, deren pharmazeutische Zusammensetzungen und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE1524T1 true ATE1524T1 (de) 1982-09-15

Family

ID=21809395

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80300821T ATE1524T1 (de) 1979-03-21 1980-03-19 Phenyl- oder phenoxy-substituierte spiroimidazolidindion-derivate, deren pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung.

Country Status (15)

Country Link
US (1) US4181729A (de)
EP (1) EP0017379B1 (de)
JP (1) JPS55127376A (de)
AR (1) AR222695A1 (de)
AT (1) ATE1524T1 (de)
AU (1) AU516325B2 (de)
DE (1) DE3060818D1 (de)
DK (1) DK120780A (de)
ES (1) ES8103058A1 (de)
FI (1) FI800871A (de)
GR (1) GR67200B (de)
IE (1) IE49563B1 (de)
IL (1) IL59615A0 (de)
PH (1) PH13951A (de)
PT (1) PT70981A (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4283409A (en) * 1979-10-29 1981-08-11 Pfizer Inc. Imidazolone derivatives
AU532110B2 (en) * 1979-11-13 1983-09-15 Ici Ltd. Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
US4870084A (en) * 1982-03-16 1989-09-26 Pfizer Inc. Bicyclic benzo fused pyran compounds used for nausea treatment and prevention
US4863934A (en) * 1982-03-16 1989-09-05 Pfizer Inc. Bicyclic benzo fused pyran compounds used for producing analgesia
US4486428A (en) * 1982-03-16 1984-12-04 Pfizer Inc. Bicyclic benzo fused compounds
US4841078A (en) * 1982-03-16 1989-06-20 Pfizer Inc. Benzopyrans
US4438272A (en) 1982-04-15 1984-03-20 Alcon Laboratories, Inc. Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
US4464385A (en) * 1982-04-15 1984-08-07 Alcon Laboratories, Inc. Treatment of diabetic complications with hydantoins
IL68314A0 (en) * 1982-04-15 1983-07-31 Alcon Lab Inc Method and composition for inhibiting aldose reductase activity and process for preparing spirofluorofluoren and spiro-difluorofluoren compounds
US4436745A (en) 1982-04-15 1984-03-13 Alcon Laboratories, Inc. Method of inhibiting aldose reductase activity
US4556670A (en) * 1982-12-06 1985-12-03 Pfizer Inc. Spiro-3-hetero-azolones for treatment of diabetic complications
ZA839023B (en) * 1982-12-06 1985-07-31 Pfizer Spiro-3-hetero-azolones for treatment of diabetic complications
DE3561198D1 (en) * 1984-03-23 1988-01-28 Pfizer Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications
US5340829A (en) * 1984-11-20 1994-08-23 Washington Research Foundation Immunoregulatory agents
US4966911A (en) * 1984-11-20 1990-10-30 Washington Research Foundation Immunoregulatory agents
WO1992000071A1 (en) * 1989-02-10 1992-01-09 Washington Research Foundation Immunoregulatory agents
ES2062125T3 (es) * 1989-02-22 1994-12-16 Sanwa Kagaku Kenkyusho Co Una composicion farmaceutica que contiene derivados de hidantoina.
DE10210195B4 (de) 2002-03-07 2005-12-15 Schwarz Pharma Ag Verwendung von 1,3-Diazaspiro-[4,5]decan-2,4-dithion zur Behandlung von Schmerz
DK3013796T3 (da) * 2013-06-27 2020-03-16 Lg Chemical Ltd Biarylderivater som gpr120-agonister
US11926601B1 (en) 2023-08-29 2024-03-12 King Faisal University 5-spiro 9,10-dihydroanthracene derivative of imidazolidine-2,4-dione as an anticancer agent

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2872454A (en) * 1959-02-03 Spiro-hydantoins from x-chloro-
US2716648A (en) * 1955-08-30 Hydantoin derivatives
DE1135915B (de) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4189587A (en) * 1977-04-05 1980-02-19 Ciba-Geigy Corporation 1,3-Diaminomethyl-hydantoin additives for lubricating oils
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4127665A (en) * 1978-01-18 1978-11-28 Pfizer Inc. Thienohydantoin derivatives

Also Published As

Publication number Publication date
US4181729A (en) 1980-01-01
ES489752A0 (es) 1981-02-16
ES8103058A1 (es) 1981-02-16
IL59615A0 (en) 1980-06-30
EP0017379A1 (de) 1980-10-15
JPS55127376A (en) 1980-10-02
DE3060818D1 (en) 1982-10-28
DK120780A (da) 1980-09-22
AR222695A1 (es) 1981-06-15
PT70981A (en) 1980-04-01
GR67200B (de) 1981-06-24
IE49563B1 (en) 1985-10-30
AU516325B2 (en) 1981-05-28
IE800571L (en) 1980-09-21
PH13951A (en) 1980-11-06
FI800871A (fi) 1980-09-22
AU5662480A (en) 1980-09-25
JPH0141629B2 (de) 1989-09-06
EP0017379B1 (de) 1982-09-08

Similar Documents

Publication Publication Date Title
ATE1524T1 (de) Phenyl- oder phenoxy-substituierte spiroimidazolidindion-derivate, deren pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung.
ATE26280T1 (de) 7-acylamino-3-vinylcephalosporansaeurederivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen, ihre ausgangsverbindungen und deren herstellung.
DE3582952D1 (de) Dihydropyridin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
IT8019049A0 (it) Composti 2 penem, metodo per laloro preparazione e composizioni farmaceutiche contenenti tali composti.
ATE17725T1 (de) Gegen entzuendung wirksame 5-substituierte 2,3diaryl-thiophene, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE3680877D1 (de) Thiazolverbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE8892T1 (de) Substituierte azabicyclooctancarboxylsaeure, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3777122D1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3767789D1 (de) Substituierte aminodihydrooxazole, -thiazole und -imidazole, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE3483308D1 (de) Semicarbazid-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE10634T1 (de) Pyrazoloindazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitung.
DE3586817D1 (de) 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3481418D1 (de) Substituierte spiropyridinderivate, diese enthaltende pharmazeutische zubereitungen, verfahren zu ihrer herstellung und zubereitungen.
DE3380989D1 (de) 2-aminobenzosaeurederivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen.
DE3684803D1 (de) Dihydropyridin-alkanolamine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE3425T1 (de) Hypoglykaemische guanylamidine, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE6772T1 (de) Tetrahydrofluoren-verbindungen, verfahren zu ihrer herstellung und deren pharmazeutische zusammensetzungen.
ATE11288T1 (de) Thioalkylamid des nicotinsaeure-1-oxids, seine salze, verfahren zu ihrer herstellung und pharmazeutische zusammenstellungen.
DE3577437D1 (de) Organo-silikon-verbindungen, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen.
ATE4900T1 (de) 1,2,4-triazin-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen.
ATE10497T1 (de) Benzochinolizine, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen.
ATE2673T1 (de) Phenothiazinderivate, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung.
ATE12097T1 (de) Diphenylalkanaether- und diphenylalkanonoximaether- derivate, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und ihre verwendung.
ATE11914T1 (de) Fungizide mittel, verfahren zu deren herstellung, und diese enthaltende pharmazeutische zusammenstellungen.
ATE12041T1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties